YM 638
Alternative Names: YM 16638Latest Information Update: 09 Aug 2002
At a glance
- Originator Yamanouchi
- Class Antiasthmatics; Antiulcers; Cytoprotectives
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Hyperlipidaemia; Peptic ulcer